| 2021 |
Cavβ3 (CACNB3) interacts with the IP3 receptor (co-immunoprecipitated in pancreatic β-cells) and, independently of its role as a Cav channel subunit, reduces IP3-dependent Ca2+ release from the ER, thereby suppressing CREB activity, MAFA protein levels, Ca2+ oscillation frequency, and glucose-induced insulin secretion in a concentration-dependent manner. CACNB3 knockout by CRISPR/Cas9 in INS-1 cells increased all these parameters without altering Cav channel currents. |
CRISPR/Cas9 knockout in INS-1 cells, co-immunoprecipitation, Ca2+ imaging, electrophysiology, Western blot, gene expression profiling |
Diabetes |
High |
34426509
|
| 2023 |
CACNB3 exclusively facilitates ATP-dependent migration of migratory dendritic cells (migDCs) but not LPS-dependent migration. Mechanistically, CACNB3 regulates ATP-induced IP3 receptor-controlled Ca2+ release from the ER, which suppresses adhesion molecule expression, promotes cell detachment, and initiates migration. Cacnb3-deficient migDCs show impaired migration after ATP exposure both in vitro and in vivo during tissue damage. |
Cacnb3 knockout mice, in vitro migration assays, in vivo tissue-damage model, Ca2+ imaging, adhesion molecule expression analysis |
Science advances |
High |
37729408
|
| 2024 |
In brain microvascular endothelial cells (BMECs), Cavβ3 interacts with IP3 receptor proteins (co-immunoprecipitation + mass spectrometry) and controls IP3-dependent Ca2+ release independently of its role as a Cav channel subunit. Absence of Cavβ3 (Cavβ3-/- mice) enhanced thrombin-stimulated IP3-dependent Ca2+ release and MLC phosphorylation, impairing ZO-1 organization and reducing transendothelial resistance; these effects were abolished by MLCK inhibitor ML-7. Expression of Cacnb3 cDNA in Cavβ3-/- BMECs restored wild-type phenotype. In vivo, loss of Cavβ3 reduced blood-brain barrier integrity and worsened experimental autoimmune encephalomyelitis. |
Cavβ3-/- knockout mice, co-immunoprecipitation + mass spectrometry, Ca2+ imaging, electrophysiology, transendothelial resistance assay, immunofluorescence (ZO-1), MLCK inhibitor rescue, cDNA rescue, EAE model |
Arteriosclerosis, thrombosis, and vascular biology |
High |
38957986
|
| 2019 |
Cavβ3 (encoded by Cacnb3) negatively regulates fibroblast migration: Cacnb3-deficient primary mouse embryonic fibroblasts and siRNA-treated wild-type fibroblasts showed faster scratch-assay gap closure in vitro, and Cacnb3 KO mice exhibited significantly faster wound closure in vivo in a dorsal skinfold chamber model. |
Scratch migration assay on Cavβ3-/- MEFs and siRNA-treated fibroblasts, in vivo dorsal skinfold chamber wound-healing model in Cavβ3 KO mice |
Journal of visualized experiments : JoVE |
Medium |
31609328
|
| 2006 |
Cacnb3 shows specific spatial and temporal expression in mouse placenta. Deletion of Cacnb3 does not produce a strong placental phenotype overall, but sporadic labyrinthine architecture phenotype with reduced fetal blood vessel density and decreased pericyte number was observed. Down-regulation of Cacnb3 did not rescue placental hyperplasia in interspecies hybrid placentas, indicating its upregulation there is a downstream event. |
Cacnb3 knockout mice, histological analysis of placenta, expression analysis |
Placenta |
Medium |
16822546
|
| 2015 |
CACNB3 mRNA is a direct target of miR-34a; luciferase reporter or equivalent direct target validation confirmed CACNB3 as a miR-34a target in neuronal cells derived from human iPSCs. |
miR-34a target validation in human iPSC-derived neuronal cultures (direct miRNA target assay); context: BD risk gene network |
Molecular psychiatry |
Medium |
25623948
|
| 2015 |
Knockdown of CACNB3 in fibroblasts altered baseline circadian rhythm amplitude but did not affect lithium's ability to amplify circadian rhythms (in contrast to CACNA1C or CACNA1D knockdown, which eliminated lithium's amplification effect). |
siRNA knockdown of CACNB3 in fibroblasts, bioluminescent Per2::luc reporter assay for circadian rhythms |
Neuropharmacology |
Medium |
26476274
|
| 1995 |
The human CACNLB3 (CACNB3) gene spans approximately 8 kb and comprises 13 exons, most located within ~5 kb; gene structure was determined, providing the genomic basis for studying the beta-3 subunit of voltage-dependent calcium channels expressed in pancreatic islets. |
Genomic cloning, exon-intron structure determination, comparative genomic sequencing |
Genomics |
Medium |
7557998
|
| 2026 |
A homozygous missense mutation p.Gly106Arg in the SH3 domain of CaVβ3 (CACNB3) co-segregates with idiopathic infantile nystagmus. Calcium imaging indicated the mutation may impair voltage-gated calcium channel function at the plasma membrane and increase IP3 receptor-mediated Ca2+ release from the ER. Co-localization studies showed reduced plasma membrane localization of the calcium channel bearing the mutant subunit. |
Linkage analysis, whole exome sequencing, Sanger sequencing, calcium imaging, co-localization studies |
Brain communications |
Medium |
41822111
|
| 2001 |
Sequencing of the CACNB3 coding region in families with distal hereditary motor neuropathy type II linked to chromosome 12q24.3 found no disease-causing mutations, excluding CACNB3 as the causal gene for this condition. |
DNA sequencing of coding regions, mutation analysis |
Annals of human genetics |
Medium |
11851982
|